Cargando…

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance

Breast cancer relapse, in a large number of patients, after initial response to standard of care therapy warrants development of novel therapies against recurrent and metastatic cancer. Cancer stem cells (CSCs), present in breast tumors while being intrinsically resistant to conventional therapy, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dave, Bhuvanesh, Mittal, Vivek, Tan, Nicholas M, Chang, Jenny C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496111/
https://www.ncbi.nlm.nih.gov/pubmed/22264257
http://dx.doi.org/10.1186/bcr2938